Oral Apremilast Achieves Statistical Significance for the Primary...
Celgene International Sarl, a subsidiary of Celgene Corporation today presented the results from PALACE-1, the Company's first Phase III study in psoriatic arthritis, at the American College of Rheumatology annual meeting in Washington, D.C. The company previously announced statistical significance for the primary endpoint of ACR20 for patients ... (more)
Join the discussion below, or Read more at Freshnews.
#1 Dec 12, 2012
Looking for more information on how Apremilast works? You can learn it here: http://www.rxwiki.com/apremilast
Add your comments below
|Arthritis Foods to Avoid (Sep '10)||Oct '13||Miya Allen||7|
|Many Psoriasis Patients Are Undertreated, Study... (Aug '13)||Aug '13||Alfie||2|
|Secrets To Mortgage Free Life (Aug '08)||Mar '13||Mike caprio||41|
|Psoriatic arthritis screening tools. (Nov '10)||Mar '13||gdeborah||6|
|Leflunomide considered safe, effective for psor... (Jan '13)||Mar '13||Roxy||3|
|Apremilast ESTEEM Program Meets Primary and Maj... (Jan '13)||Jan '13||kmc2749||2|
|TSA Blog: Log Complaints To Transportation Secu... (Sep '08)||Nov '10||La Chica||2|
Find what you want!
Search Psoriatic Arthritis Forum Now
Copyright © 2016 Topix LLC